Novavax is on the cusp of having its coronavirus vaccine approved by federal regulators, joining the ranks of Pfizer, Moderna and Johnson & Johnson. However, the drugmaker has struggled for more than a year to manufacture these shots. The two-dose injection has already been approved by the World Health Organization. Here's why it's different from the mRNA vaccines and how effective it is against COVID-19.
In a 21-0 vote with one abstention, advisers to the Food and Drug Administration recommended that the agency authorize Novavax's two-dose vaccine against COVID-19. In comments to the committee before its vote, Dr. Peter Marks, the FDA's top vaccine official said, "We speak to making available …
Live news & updates on the Coronavirus (COVID-19) outbreak News, Prevention Tips, and Resources on COVID-19
Novavax hitched its wagon to the global coronavirus pandemic. Before most Americans truly grasped the scope of the danger, the small Maryland biotech …
On Monday (Jun 14), Novavax announced that its vaccine has 93% efficacy against Covid-19 variants. The American biotechnology company also claimed that their vaccine candidate was found to have a 91% efficacy in high-risk populations during the phase 3 trial. “Our vaccine works very well even though …
June 7 (Reuters) - Novavax Inc (NVAX.O), opens new tab said on Tuesday that its COVID-19 vaccine initially available in the United States, if authorized, will be manufactured by the Serum Institute of India. "So all vaccines that are being distributed globally commercially are being made in a single …
Novavax announced that it will delay the submission of its Covid-19 vaccine to the Food and Drug Administration for emergency use authorization until …
Check out our Coronavirus Hub featuring magazines and Storyboards from Flipboard and publishers for more information on the pandemic, remote working, self-isolation, and everything else you need to know.
A collection of coronavirus news, analysis and best practices from the world's most trustworthy sources.
